摘要
目的观察消癌平注射液联合GP方案治疗晚期非小细胞肺癌的临床疗效。方法将56例晚期非小细胞肺癌随机分为两组,对照组28例应用GP方案化疗,试验组28例应用GP方案化疗联合消癌平注射液,2个周期后评价疗效。结果两组患者近期疗效比较差异无统计学意义(P>0.05),但试验组患者治疗后生活质量明显优于对照组(P<0.05),毒副反应轻于对照组(P<0.05)。结论消癌平注射液能减轻GP方案对机体的毒副反应,增强患者对化疗的耐受性。
Objective To observe the effect of Xiaoaiping injection combined with GP regi men in the treatment of advanced non small cell lung cancer. Methods The 56 patients with ad vanced non-small cell lung cancer were randomly divided into two groups, the 28 patients in the control group used GP regimen chemotherapy, and the 28 patients in the treatment group used GP regimen chemotherapy combined with Xiaoaiping injection, the effect was evaluated after 2 cycles of chemotherapy. Results The recent effects of the two groups were not statistically dif ferent（P^0.05） ; the quality of life was better than those of the control group（P〈0.05） ; the toxicities were lower than those of the control group（P〈0.05）. Conclusion Xiaoaiping injection can reduce the toxicities of GP regimen, and can improve immunity and the tolerance of chemo therapy.
出处
《青岛医药卫生》
2012年第4期246-248,共3页
Qingdao Medical Journal
关键词
非小细胞肺癌
消癌平注射液
化疗
Non-small cell lung cancer
Xiaoaiping injection
Chemotherapy
